Impact of IPT With Sulfadoxin Pyrimetamin on Pregnant Women and Their Babies Outcomes in Peri-urban Areas of Bobo-Dioulasso(Burkina Faso)

NCT01255605 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 772

Last updated 2012-06-18

No results posted yet for this study

Summary

The purpose of this is to determine the impact of intermittent preventive treatment (IPT) with sulfadoxine-pyrimethamine (SP) on the morbidities associated with malaria in pregnant women and newborns in rural peri-urban areas of Bobo-Dioulasso, 5 years after its implemented.

Conditions

  • Malaria, Pregnancy

Sponsors & Collaborators

  • Université Polytechnique de Bobo-Dioulasso

    lead OTHER

Principal Investigators

  • Mamoudou Cisse, MD · Centre MURAZ Research Institute

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Completion
2011-06-30

Countries

  • Burkina Faso

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01255605 on ClinicalTrials.gov